Inaktiver Wert

Rennova Health Inc Aktie Nasdaq

Aktien

Schlusskurs Nasdaq Andere Börsenplätze
- ^USD	-

RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	24.07.20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	17.07.20
RENNOVA HEALTH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	08.07.20
RENNOVA HEALTH : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	29.06.20
RENNOVA HEALTH, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	16.06.20

Manager	Titel	Alter	Seit
Darrell Peterson CEO	Chief Executive Officer	65	14.05.23
Gerard Dab CHM	Chairman	75	14.05.23
Sebastien Sainsbury IRO	Public Communications Contact	61	-

Aufsichtsräte	Titel	Alter	Seit
Gerard Dab CHM	Chairman	75	14.05.23
Sharon Hollis CEO	Chief Executive Officer	47	01.07.11
Francisco Roca BRD	Director/Board Member	58	14.05.23

Sektor

	% 1. Jan.	Kap.
SONIC HEALTHCARE LIMITED	-16,33 %	8,43 Mrd.
RADNET, INC.	+40,93 %	3,62 Mrd.
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD.	-35,59 %	2,61 Mrd.
SYNLAB AG	-7,88 %	2,48 Mrd.
DR. LAL PATHLABS LIMITED	-8,36 %	2,34 Mrd.
NEOGENOMICS, INC.	-5,93 %	1,94 Mrd.
FLEURY S.A.	-18,96 %	1,56 Mrd.
DIAN DIAGNOSTICS GROUP CO.,LTD.	-38,35 %	1,26 Mrd.
METROPOLIS HEALTHCARE LIMITED	+6,91 %	1,1 Mrd.